ÐÜèÊÓÆµ

Skip to Content
Resources

ÐÜèÊÓÆµComment Letter on Interchangeable Biosimilar Applications

Comment Letter

ÐÜèÊÓÆµsubmitted comments to FDA Commissioner Robert M. Califf, M.D., regarding interchangeable biosimilar applications.

Document Info

Published on Aug 20, 2024

Download and read the full Resource.

Resource Details